| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.0B | $3.7B | $3.4B | $3.0B | $0.7B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | $1.6B | $1.6B | $1.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Operating Income | $0.5B | $0.5B | $0.4B | $0.4B | $0.2B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.3B | $0.3B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $7.40 | $6.82 | $5.77 | $4.60 | $-1.34 | $1.34 | $1.96 | $1.16 |
| EPS (Diluted) | $6.84 | $6.45 | $5.50 | $4.41 | $-1.32 | $1.31 | $1.91 | $1.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B | $5.8B | $5.9B | $5.4B | $4.7B | $4.9B | $4.7B | $3.3B |
| Current Assets | $4.3B | $4.0B | $4.2B | $3.7B | $3.3B | $3.4B | $2.9B | $2.1B |
| Cash & Equivalents | $1.0B | $1.3B | $1.3B | $1.1B | $1.3B | $1.4B | $0.8B | $1.1B |
| Total Liabilities | $5.2B | $4.6B | $4.6B | $4.2B | $3.5B | $3.5B | $3.1B | $2.1B |
| Current Liabilities | $3.9B | $3.2B | $2.7B | $2.4B | $1.9B | $1.9B | $1.6B | $1.4B |
| Stockholders' Equity | $1.3B | $1.2B | $1.2B | $1.2B | $1.3B | $1.4B | $1.6B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.7B | $0.6B | $0.7B | $0.4B | $0.3B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.2B | $-0.2B | $-0.5B | $-0.1B | $-0.1B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.8B | $-0.1B | $-0.1B | $-0.0B | $-0.2B | $0.0B | $0.4B | $0.0B |